Skip to main content
Erschienen in: Pediatric Nephrology 6/2006

01.06.2006 | Original Article

Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora

verfasst von: Ipek Akil, Ozge Yilmaz, Semra Kurutepe, Kenan Degerli, Salih Kavukcu

Erschienen in: Pediatric Nephrology | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Enteric flora constitutes 95% of the cells in the human body. It has been shown that the bacterial content of this flora is affected by diet and changes in nutrition. Considering that urinary tract infections (UTI) are mostly due to ascending infections from the gut flora, the importance of the elements of this flora and their characteristics becomes more evident. The aim of this study was to evaluate the influence of oral Saccharomyces boulardii (S. boulardii) intake on the number of Escherichia coli (E. coli) colonies in the colon. This study was carried out with 14 boys and 10 girls (total of 24 children) aged between 36 and 192 months (mean: 104.3±45.1 months). A commercial capsule or powder containing 5 billion colony-forming units (cfu) of S. boulardii was administered once a day for 5 days. The number of E. coli and yeast colonies was measured in the stool samples of the study group before and after the use of this drug. Before treatment, the mean number of E. coli colonies in g/ml stool was 384,625±445,744. This number decreased significantly to 6,283±20,283 after treatment (p=0.00). S. boulardii was not detected in stool before treatment and the number of colonies increased to 11,047±26,754 in g/ml stool. S. boulardii may be effective in reducing the number of E. coli colonies in stool. The influence of this finding on clinical practice such as prevention of UTI needs to be clarified by further studies.
Literatur
1.
Zurück zum Zitat Stull TL, LiPuma JJ (1991) Epidemiology and natural history of urinary tract infections in children. Med Clin North Am 75:287–297CrossRef Stull TL, LiPuma JJ (1991) Epidemiology and natural history of urinary tract infections in children. Med Clin North Am 75:287–297CrossRef
2.
Zurück zum Zitat Dunne C, O’Mahony L, Murphy L, Thornton G, Morrissey D, O’Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O’Sullivan GC, Shanahan F, Collins JK (2001) In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73:386S–392SCrossRef Dunne C, O’Mahony L, Murphy L, Thornton G, Morrissey D, O’Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O’Sullivan GC, Shanahan F, Collins JK (2001) In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73:386S–392SCrossRef
3.
Zurück zum Zitat Elmer GW, Surawicz CM, McFarland LV (1996) Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275:870–876CrossRef Elmer GW, Surawicz CM, McFarland LV (1996) Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275:870–876CrossRef
4.
Zurück zum Zitat McFarland LV, Elmer GW (1995) Biotherapeutic agents: past, present and future. Microecology Ther 23:46–73 McFarland LV, Elmer GW (1995) Biotherapeutic agents: past, present and future. Microecology Ther 23:46–73
5.
Zurück zum Zitat McFarland LV, Bernasconi P (1993) Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microb Ecol Health Dis 6:157–171CrossRef McFarland LV, Bernasconi P (1993) Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microb Ecol Health Dis 6:157–171CrossRef
6.
Zurück zum Zitat Czerucka D, Dahan S, Mograbi B, Rossi B, Rampal P (2000) Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 68:5998–6004CrossRef Czerucka D, Dahan S, Mograbi B, Rossi B, Rampal P (2000) Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 68:5998–6004CrossRef
7.
Zurück zum Zitat Kontiokari T, Nuutinen M, Uhari M (2004) Dietary factors affecting susceptibility to urinary tract infection. Pediatr Nephrol 19:378–383CrossRef Kontiokari T, Nuutinen M, Uhari M (2004) Dietary factors affecting susceptibility to urinary tract infection. Pediatr Nephrol 19:378–383CrossRef
8.
Zurück zum Zitat Reid G (2001) Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 73(Suppl):437S–443SCrossRef Reid G (2001) Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 73(Suppl):437S–443SCrossRef
9.
Zurück zum Zitat Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82:103–108CrossRef Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82:103–108CrossRef
10.
Zurück zum Zitat Mombelli B, Gismondo MR (2000) The use of probiotics in medical practice. Int J Antimicrob Agents 16:531–536CrossRef Mombelli B, Gismondo MR (2000) The use of probiotics in medical practice. Int J Antimicrob Agents 16:531–536CrossRef
11.
Zurück zum Zitat Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, Czerucka D (2003) Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 71:766–773CrossRef Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, Czerucka D (2003) Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 71:766–773CrossRef
12.
Zurück zum Zitat Rodrigues AC, Cara DC, Fretez SH, Cunha FQ, Vieira EC, Nicoli JR, Vieira LQ (2000) Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 89:404–414CrossRef Rodrigues AC, Cara DC, Fretez SH, Cunha FQ, Vieira EC, Nicoli JR, Vieira LQ (2000) Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 89:404–414CrossRef
13.
Zurück zum Zitat Reid G, Burton J (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4:319–324CrossRef Reid G, Burton J (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4:319–324CrossRef
14.
Zurück zum Zitat Howell AB, Vorsa N, Der Marderosian A, Foo LY (1998) Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med 339:1085–1086CrossRef Howell AB, Vorsa N, Der Marderosian A, Foo LY (1998) Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med 339:1085–1086CrossRef
15.
Zurück zum Zitat Burkhardt O, Kohnlein T, Pletz M, Welte T (2005) Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole. Scand J Infect Dis 37:69–71CrossRef Burkhardt O, Kohnlein T, Pletz M, Welte T (2005) Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole. Scand J Infect Dis 37:69–71CrossRef
16.
Zurück zum Zitat Schlager TA, Hendley JO, Bell AL, Whittam TS (2002) Clonal diversity of Escherichia coli colonizing stools and urinary tracts of young children. Infect Immun 70:1225–1229CrossRef Schlager TA, Hendley JO, Bell AL, Whittam TS (2002) Clonal diversity of Escherichia coli colonizing stools and urinary tracts of young children. Infect Immun 70:1225–1229CrossRef
17.
Zurück zum Zitat Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M (2001) Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 322:1571–1573CrossRef Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M (2001) Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 322:1571–1573CrossRef
18.
Zurück zum Zitat Reid G, Bruce AW, Taylor M (1992) Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 14:11–16PubMed Reid G, Bruce AW, Taylor M (1992) Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 14:11–16PubMed
Metadaten
Titel
Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora
verfasst von
Ipek Akil
Ozge Yilmaz
Semra Kurutepe
Kenan Degerli
Salih Kavukcu
Publikationsdatum
01.06.2006
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 6/2006
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0088-4

Weitere Artikel der Ausgabe 6/2006

Pediatric Nephrology 6/2006 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.